| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015874297 |
| P356 | DOI | 10.1007/S00467-015-3133-3 |
| P698 | PubMed publication ID | 26135137 |
| P5875 | ResearchGate publication ID | 279730273 |
| P2093 | author name string | Indira Agarwal | |
| Swasti Chaturvedi | |||
| Ratna Prabha | |||
| Afsana Jahan | |||
| Denise Fleming | |||
| Binu Mathew | |||
| P2860 | cites work | The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. | Q33943247 |
| Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients | Q34257909 | ||
| Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome | Q34362680 | ||
| Experience with tacrolimus in children with steroid-resistant nephrotic syndrome | Q37229944 | ||
| Measurement and estimation of GFR in children and adolescents | Q37612658 | ||
| Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation. | Q37808608 | ||
| Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. | Q38050959 | ||
| AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients | Q40424283 | ||
| Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin | Q40963647 | ||
| Clinical pharmacokinetics of tacrolimus | Q41096852 | ||
| Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome | Q42689190 | ||
| Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection | Q43291782 | ||
| Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients | Q43620679 | ||
| Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up | Q43935632 | ||
| Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. | Q43961758 | ||
| Pharmacokinetics of tacrolimus in paediatric renal transplant recipients | Q44101747 | ||
| Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children | Q44187095 | ||
| Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients | Q44844484 | ||
| Changes in tacrolimus distribution in blood and plasma protein binding following liver transplantation | Q45073040 | ||
| Tacrolimus clearance is age-dependent within the pediatric population | Q45871846 | ||
| Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome | Q47417726 | ||
| The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipients | Q61409833 | ||
| Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants | Q73621755 | ||
| Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome | Q95551297 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1961-1967 | |
| P577 | publication date | 2015-07-02 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome | |
| P478 | volume | 30 |
| Q53702610 | Calcineurin inhibitors and nephrotoxicity in children. |
| Q52594698 | Population Pharmacokinetics of Tacrolimus in Children with Nephrotic Syndrome. |
| Q26747770 | Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children |
| Q49500608 | Steroid-resistant nephrotic syndrome: past and current perspectives |
Search more.